PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Feb-2022 Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy in Hemophilia B – Data Presented at EAHAD 2022 CSL Behring
08-Feb-2022 Sanofi unveils new corporate brand and logo – unites the company under one purpose and a single identity Sanofi
08-Feb-2022 BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein BRAIN Biotech AG
08-Feb-2022 Main Capital Backs GxP Compliance Specialist biomedion B3C newswire
08-Feb-2022 Evolva appoints Christian Wichert as new CEO to boost growth strategy and enter its next phase of development and commercialization Evolva Holding SA
08-Feb-2022 Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office Relief Therapeutics Holding SA
07-Feb-2022 DFE Pharma appoints Martti Hedman as new CEO DFE Pharma
07-Feb-2022 Devyser acquires Italian SmartSeq and strengthens position in genetic data analysis Devyser
07-Feb-2022 BMG LABTECH Launches the New VANTAstar™: Microplate Reading, Made Easy B3C newswire
04-Feb-2022 Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders PHARMAP 2022
04-Feb-2022 Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets Evotec SE
04-Feb-2022 Evotec expands sustainability at Dorothy Crowfoot Hodgkin Campus Evotec
04-Feb-2022 Sanofi unveils new corporate brand and logo – unites the company under one purpose and a single identity Sanofi
04-Feb-2022 Thermo Scientific Nicolet RaptIR FTIR Microscope Quickly Collects and Analyzes High-Spatial Resolution Data with Agility and Acuity Thermo Scientific
04-Feb-2022 Invitation: Straumann Group 2021 full-year financial results webcast Straumann Holding AG
04-Feb-2022 Nass Valley Gateway Ltd.: Nass Valley Gardens Inc. Announces It Will File to Launch a Reg A+ Public Offering Nass Valley Gateway Ltd.
04-Feb-2022 Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange Cassiopea S.p.A.
03-Feb-2022 Synaffix Inks Deal with MacroGenics to Enable Next Generation ADCs Synaffix
03-Feb-2022 pharmasol completes merger with PharmaLex Group pharmasol
03-Feb-2022 Reaction Biology Announces Integrated Drug Discovery Solutions: The Reaction Oncology Platform Reaction Biology